Olema Pharmaceuticals, Inc. Common Stock (OLMA) Stock Price

OLMAStock
$10.91+81.08%52W
Market Cap$954.60M
P/E
PEG Ratio
Div yield
Beta1.98

OLMA Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-64.70%
Price vs S&P 500 (4W)-13.29%
VGM Score43.94

OLMA Earnings Surprise History

Q2 25-0.51est. -0.44
Q3 25-0.49est. -0.47
Q4 25-0.50est. -0.53
Q1 26-0.52est. -0.54
Q2 26-0.61est. -0.56

OLMA Analyst Recommendations

May 2026
Jun 2026
Jul 2026
Aug 2026
4.26
4.26
4.22
4.22

Industry Peers — Pharmaceuticals(571)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
OLMAOlema Pharmaceuticals, Inc. Common Stock
C$10.91
LLYEli Lilly & Co.DBB$1233.66
JNJJohnson & JohnsonDCB$273.14
ABBVABBVIE INC.DCB$265.79
MRKMerck & Co., Inc.DCA$156.45
NVSNovartis AGCCC$159.98
AZNAstraZeneca PLCCBC$169.66
NVONovo-Nordisk A/SBCC$48.66
ABTAbbott LaboratoriesCCB$116.13
PFEPfizer Inc.CDC$28.57
VRTXVertex Pharmaceuticals IncDCB$552.85

About Olema Pharmaceuticals, Inc. Common Stock

Olema Pharmaceuticals is a clinical-stage biopharmaceutical company focused on targeted therapies for women's cancers. Its pipeline includes OP-1250, which has completed preclinical studies, and OP-3136. The company aims to improve outcomes for women living with cancer.